London Business News | Londonlovesbusiness.com
7 months agoGrowth hacking
Novo Nordisk's record-breaking growth highlights 'insatiable demand' for weight loss drugs
Novo Nordisk achieved a 20-year high in revenue growth rate, beating estimates for FY2023 revenue and earnings.
The growth is not demand constrained but production capacity constrained, with an insatiable demand for weight loss drugs. [ more ]